期刊文献+

糖基化在白内障发病中的作用和防治对策 被引量:3

Effect of glycosylation in cataract development and the preventive strategies
下载PDF
导出
摘要 晶状体蛋白质糖基化在白内障发生、发展中起的作用已被长期关注。本综述从糖基化的概念、晶状体蛋白的糖基化、晶状体酶和受体的糖基化3方面,系统论述了糖基化的作用机制及其在年龄相关性和糖尿病性白内障形成中的重要作用,并介绍了抑制糖基化的方法,如AGEs形成抑制剂、AGEs交联阻断剂,这些具有针对性的治疗方法为白内障的治疗提出了有效可行的指导依据。 · The effect of lens protein glycosylation in cataract formation and development has long been concerned about. By summarizing the concept of glycosylation, glycosylation of lens crystallin, enzymes and receptors, we attempted to conduct a systematic review of the effect of glycosylation on age-related cataract and diabetic cataract. The preventive strategies to glycosylation, such as advance glycation end product and cross-linking inhibitors, were also summarized to offer an effective and feasible guideline for clinical therapy of cataract.·
出处 《国际眼科杂志》 CAS 2005年第3期508-512,共5页 International Eye Science
基金 国际合作研究项目基金(No.070667/Z/03)~~
关键词 糖基化 白内障 晶状体酶 糖尿病 抑制剂 glycosylation cataract mechanism preventive strategies
  • 相关文献

参考文献36

  • 1Ramalho J, Marques C, Pereira P, Mota MC. Crystallin composition of human cataractous lens may be modulated by protein glycation. Graefes Arch Clin Exp Ophthalmol, 1996;234(1):232-238
  • 2Prabhakaram M, Katz ML, Ortwerth BJ. Glycation mediated crosslinking between α-crystallin and MP26 in intact lens membranes. Mech Ageing Dev, 1996;91:65-78
  • 3Pokupec R, Kalauz M, Turk N. Advanced glycation endproducts in human diabetic and non-diabetic cataractous lenses. Graefes Arch Clin Exp Ophthalmol, 2003;241(5):378-384
  • 4赵惠仁,Abra.,EC.糖基化终产物在白内障晶状体膜外在蛋白中累积的研究[J].徐州医学院学报,1998,18(6):437-441. 被引量:1
  • 5Swamy MS, Tsai C, Abragam A. Glycation mediated lens crystalline aggregation and cross-linking by various sugars and sugar phosphates in vitro.Exp Eye Res, 1993;56(2):177-185
  • 6Ganea E, Rixon KC, Harding JJ. Binding of glucose, galactose and pyridoxal phosphate to lens crystallins. Biochim Biophys Acta, 1994;1226:286-290
  • 7Franke S, Dawczynski J, Strobel J. Increased levels of advanced glycation end products in human cataractous lenses. J Cataract Refract Surg, 2003;29(5):998-1004
  • 8Bhat SP. Crystallins, genes and cataract. Prog Drug Res, 2003; 60:205-262
  • 9Graw J, Loster J, Soewarto D. V76D mutation in a conserved γ D-crystallin region leads to dominant cataracts in mice. Mamm Genome, 2002;13(8):452-455
  • 10Hong SB, Lee KW, Handa JT. Effect of advanced glycation end products on lens epithelial cells in vitro. Biochem Biophys Res Commun, 2000;275(1):53-59

二级参考文献23

  • 1严宏 张东杲 等.α-晶体蛋白作粉娘对糖基化诱导过氧化氢酶失活的保护[J].第四军医大学学报,1998,1:33-33.
  • 2Raza K, Harding JJ. Non-enzymic modification of lens proteins by glucose and fructose: effects of Ibuprofen [J]. Exp Eye Res 1991;52:205-212.
  • 3Derham BK, Harding JJ. The effects of aging on the chaperone-like function of rabbit α-crystallin, comparing three methods of assay[J]. Biochim Biophys Acta 1997;1336:184-187.
  • 4Jedziniak JA, Chylack LT Jr, Cheng HM, Gillis MK, Kalustian AA, Tung WH. The sorbital pathway in the human lens: aldose reductase and polyol dehydrogenase[J]. Invest Ophthalmol Vis Sci 1981;20:314-326.
  • 5Szwergold BS, Kappler F, Brown TR. Identification of fructose 3-phosphate in the lens of diabetic rats[J]. Science 1990; 247:451-454.
  • 6Van Boekel MA, Hoogakker SE, Harding JJ, de Jong WW. The influence of some post-translational modification on the chaperone-like activity of α-crystallin[J]. Ophthalmic Res 1996;28(S1):32-38.
  • 7Plater ML, Goode D, Crabbe MJ. Ibuprofen protects α-crystallin against post-translational modification by preventing protein cross-linking[J]. Ophthalmic Res 1997;29:421-428.
  • 8Yan H, Harding JJ. Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase[J]. Biochem J 1997;328:599-605.
  • 9Yan H, Harding JJ. Inactivation and loss of antigenicity of esterase by sugars and a steroid[J]. Biochim Biophys Acta 1999;1454:183-190.
  • 10Derham BK, Harding JJ. Alpha-crystallin as a molecular chaperone[J]. Prog Retina Eye Res 1999;18:463-509.

共引文献29

同被引文献23

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部